Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BRNS

Barinthus Biotherapeutics Plc ADR

Jun 18 • 04:00PM ET

0.6622

-0.0362 -5.19 %

Healthcare • Biotechnology • United Kingdom • Nano • NASD

Peers: APLM CRVO GRDX IGC LSTA NRSN PLRZ SER SKYE SNTI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.29	Insider Own	3.48%	Shs Outstand	40.85M	Perf Week	-8.53%
Market Cap	27.05M	Forward P/E	-	EPS next Y	-1.15	Insider Trans	0.00%	Shs Float	39.43M	Perf Month	-3.12%
Enterprise Value	-29.05M	PEG	-	EPS next Q	-0.28	Inst Own	19.28%	Short Float	0.01%	Perf Quarter	5.11%
Income	-52.46M	P/S	-	EPS this Y	29.88%	Inst Trans	16.18%	Short Ratio	0.05	Perf Half Y	-10.34%
Sales	0.00M	P/B	0.41	EPS next Y	0.00%	ROA	-44.81%	Short Interest	0.00M	Perf YTD	-5.42%
Book/sh	1.62	P/C	0.40	EPS next 5Y	-	ROE	-57.68%	52W High	2.92 -77.32%	Perf Year	-23.89%
Cash/sh	1.64	P/FCF	-	EPS past 3/5Y	- -	ROIC	-69.57%	52W Low	0.51 29.33%	Perf 3Y	-71.21%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.32% 7.69%	Perf 5Y	-95.37%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	21.30%	Oper. Margin	-	ATR (14)	0.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.05	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	46.92	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.05	EPS Q/Q	72.40%	SMA20	-4.08%	Beta	-0.42	Target Price	7.00
Payout	-	Debt/Eq	0.17	Sales Q/Q	-	SMA50	1.16%	Rel Volume	0.12	Prev Close	0.70
Employees	14	LT Debt/Eq	0.14	Earnings	Apr 30 BMO	SMA200	-19.06%	Avg Volume	69.43K	Price	0.66
IPO	Apr 30, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	50.00% -	Trades		Volume	8,161	Change	-5.19%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)